Drug Makers Settle Suit Over Epilepsy Treatment
Under the agreement, Kali may not introduce a generic version of Diastate and Diastate AcuDial until September 2010. Other terms of the settlement, which was reached last week at a conference in a New Jersey court, were not disclosed. The companies have 60 days to finalize the agreement.
Xcel Pharmaceuticals, which was acquired by...
To view the full article, register now.